Theleme Partners LLP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001511881

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q2 2026 · 9 positions · Total reported value $1.68B · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 30.0% · 1 new · 2 cut · 0 exited

Active Share (vs S&P 500): 87.6% · vs QQQ: 86.9% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Theleme Partners LLP disclosed 9 equity positions with a combined reported value of $1.68B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q2 2026 were MRNA ($564.27M), META ($258.80M), UBER ($230.66M). By sector, the heaviest allocations are Health Care 33.5%, Consumer Discretionary 25.4%. Versus the prior quarter, allocation shifted toward Real Estate (+6.5pp), Health Care (+6.3pp) and away from Financials (-4.5pp), Technology (-8.2pp).

Versus the prior quarter, Theleme Partners LLP opened 1 new positions, trimmed 2 and fully exited 0, a turnover rate of 30.0% of positions. The portfolio's overlap with the prior quarter was 64% of names.

The largest new positions opened in Q2 2026 were EQIX ($110.08M), HDB ($40.15M).

Of the 2 positions fully exited versus the prior quarter, the largest were FLUT ($98.49M), HOOD ($79.35M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • EQIX EQUINIX INC · $110.08M
  • HDB HDFC BANK LTD · $40.15M

Fully Exited (vs previous quarter)

  • FLUT FLUTTER ENTMT PLC · prev qtr: $98.49M
  • HOOD ROBINHOOD MKTS INC · prev qtr: $79.35M

Insider Transactions (Form 4)

Latest Theleme Partners LLP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Theleme Partners LLP is an SEC-registered 13F filer. As of Q2 2026 it reported 9 US equity positions with a combined value of $1.68B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 9 positions · $1.68B reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MRNA (MODERNA INC) at 33.5%
  • Average position size: $187.05M

Sector Tilt

  • Health Care 33.5%
  • Consumer Discretionary 25.4%
  • Financials 18.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 2 new, 4 added, 2 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: Theleme Partners LLP's latest rebalancing appears to be moderately bullish, with additions in technology and financial sectors, suggesting a positive view on these areas. The slight increase in positions across the board and the addition of new holdings indicate a proactive stance in adapting to market trends. 2. Key Moves: - Additions: - META Platforms Inc (META) - a technology company, showing confidence in the tech sector's growth potential. - TransUnion (TRU) - a credit reporting agency, reflecting an interest in the financial data and services industry. - Equinix Inc (EQIX) - a data center REIT, suggesting a bet on the demand for data center infrastructure. - Equifax Inc (EFX) - another credit reporting agency, reinforcing the interest in financial services. - HDFC Bank Ltd (HDB) - a major Indian bank, indicating a regional play on emerging markets. - Increases: - Amazon.com Inc (AMZN) - an e-commerce and cloud computing giant, with a significant boost in shares, possibly reflecting the company's diversification and market leadership. - TransUnion (TRU) - a slight increase, possibly to capitalize on its position in the financial services market. - Hold: - Moderna Inc (MRNA) - a biotech company known for its mRNA vaccine technology. - Uber Technologies Inc (UBER) - a ride-sharing and transportation company. - Sify Technologies Ltd (SIFY) - a technology services company, maintaining its position in the tech sector. - Decreases: None reported. 3. Portfolio Structure: The portfolio seems to be actively managed with a bias towards technology and financials. There's a mix of companies at different stages of maturity, from established players like Amazon to emerging ones like Meta Platforms and HDFC Bank. The risk appetite is balanced, with a diversified mix of sectors, though the technology and financials sectors are overrepresented. 4. Per-Holding One-Liner: - MRNA: Biotechnology company specializing in mRNA vaccines. - META: Social media and online advertising platform. - UBER: Ride-sharing and transportation company. - AMZN: E-commerce and cloud computing company. - TRU: Credit reporting agency. - EQIX: Data center REIT. - EFX: Credit reporting agency. - HDB: Indian bank. - SIFY: Technology services company. - Unverified: The exact benchmarks or business specifics for some ETFs are not provided. 5. One-Sentence Style Summary: Theleme Partners LLP's 2026-Q2 rebalancing reflects a bullish stance on technology and financials, with a focus on established and emerging companies in these sectors, indicating an active and sector-focused investment approach.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 33.5%
Financials 18.0%
Technology 16.6%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.06M $564.27M 33.52%
33.52%
Hold
2 459.45K $258.80M 15.37%
15.37%
Add
3 3.20M $230.66M 13.70%
13.70%
Hold
4 822.98K $196.15M 11.65%
11.65%
Add
5 2.37M $170.95M 10.15%
10.15%
Add
6 105.60K $110.08M 6.54%
6.54%
New
7 574.21K $91.14M 5.41%
5.41%
Add
8 1.55M $40.15M 2.38%
2.38%
New
9 1.28M $21.24M 1.26%
1.26%
Hold

FAQ

What did Theleme Partners LLP buy in 2026-Q2?

In its 2026-Q2 13F filing, Theleme Partners LLP reported 9 equity positions worth $1.68B in aggregate; its largest disclosed positions were MRNA ($564.27M), META ($258.80M), UBER ($230.66M).

How large is Theleme Partners LLP's portfolio?

Theleme Partners LLP reported $1.68B of long equity holdings across 9 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Theleme Partners LLP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/theleme-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →